Cannabis-based medicinal products
11/11/2019
Source: NICE (National Institute for Health and Care Excellence)
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
You may also be interested in
01/11/2018
Medical cannabis (and cannabis oils)
22/01/2021
FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)
17/06/2020
Drug licensing factsheet: cannabis, CBD and other cannabinoids
06/07/2021
Cannabis-based products for medicinal use: Frequently asked questions
13/01/2021
Guidance on analytical limits for controlled cannabinoids
01/11/2019
Cannabis (Marijuana) and Cannabinoids: What You Need To Know
11/01/2021
Cannabidiol (CBD) guidance
04/12/2020
UN Commission on Narcotic Drugs reclassifies cannabis to recognize its therapeutic uses